Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2025-12-25 @ 10:09 PM
Study NCT ID:
NCT06233058
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-31
First Post:
2023-12-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®
Sponsor:
Bio-innova Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-04-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-27
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-15
First Submit QC Date:
None
Study First Post Date:
2024-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-22
Last Update Post Date:
2024-01-31
Last Update Post Date Type:
ACTUAL